TL;DR: The Centers for Medicare & Medicaid Services modified NCD 205, the National Coverage Determination governing Medicare sweat test coverage, effective March 7, 2026. Here's what billing teams need to do.
CMS updated NCD 205 to clarify two things: the sweat test is covered when used as a diagnostic tool for cystic fibrosis, and it is explicitly not covered when used as a predictor of sympathectomy efficacy in peripheral vascular disease. The policy does not list specific CPT or HCPCS codes. If your practice bills sweat tests under Medicare, the coverage line is now clearly drawn — and claims on the wrong side of it will be denied.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Sweat Test |
| Policy Code | NCD 205 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Pulmonology, Pediatrics, Internal Medicine, Vascular Surgery |
| Key Action | Audit any sweat test claims tied to peripheral vascular disease workups and update your internal billing guidelines before March 7, 2026 |
CMS Sweat Test Coverage Criteria and Medical Necessity Requirements 2026
Under NCD 205, Medicare covers the sweat test as a diagnostic tool for cystic fibrosis. That's the covered indication. Medical necessity documentation should reflect a clinical workup consistent with cystic fibrosis diagnosis — not a general screening or a vascular evaluation.
CMS does not list specific CPT or HCPCS codes in this policy. That's a real gap for your billing team. If you're submitting sweat test claims to Medicare, you'll need to identify the procedure codes your practice uses and confirm those codes are being paired with diagnosis codes that support cystic fibrosis — not peripheral vascular disease or sympathectomy-related indications.
Prior authorization is not mentioned in NCD 205, so this policy operates on a post-payment review and medical necessity documentation basis. The risk isn't prior auth denial — it's a post-payment audit finding claims billed with the wrong clinical context. Get the documentation right on the front end.
The CMS sweat test reimbursement question comes down to this: if the claim doesn't reflect a cystic fibrosis workup, it doesn't meet medical necessity under this coverage policy. Full stop.
CMS Sweat Test Exclusions and Non-Covered Indications
The explicit exclusion in NCD 205 is the sweat test used to predict sympathectomy efficacy in peripheral vascular disease. CMS describes this use as "unproven" — the agency's language for investigational or experimental, which carries the same billing result: not covered, claim denied.
This is worth flagging specifically for vascular surgery and interventional practices. If your providers have historically ordered sweat tests as part of a peripheral vascular disease workup — perhaps to assess autonomic function before sympathectomy — those claims are outside Medicare coverage under this policy. It doesn't matter how clinically reasonable the rationale is. CMS has drawn the line.
The word "unproven" in CMS policy language isn't a soft hedge. It's a coverage determination. Claims submitted with diagnosis codes pointing to peripheral vascular disease rather than cystic fibrosis will not survive scrutiny under NCD 205.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Diagnostic workup for cystic fibrosis | Covered | Not specified in policy | Medical necessity documentation must reflect cystic fibrosis clinical context |
| Predictor of sympathectomy efficacy in peripheral vascular disease | Not Covered | Not specified in policy | Classified as "unproven" by CMS; claims will be denied |
CMS Sweat Test Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit your sweat test claims before March 7, 2026. Pull claims from the last 12–24 months and identify any where the associated diagnosis codes point to peripheral vascular disease. Those are your exposure. If you've been billing sweat tests in a vascular context, you have a retroactive risk to assess — not just a prospective one. |
| 2 | Confirm the CPT and HCPCS codes your practice uses for sweat testing. NCD 205 does not list specific codes, which means you need to identify the codes in your own charge capture and verify how they're paired with diagnosis codes. If you're not sure which codes apply, work with your billing consultant to map them before the effective date. |
| 3 | Update your internal billing guidelines to reflect the covered vs. non-covered indications. Document explicitly that sweat tests billed to Medicare require a cystic fibrosis clinical context. Add the peripheral vascular disease exclusion to your denial prevention checklist. |
| 4 | Educate ordering providers in vascular surgery and relevant specialties. The physicians who need to know about this exclusion most are the ones least likely to read a CMS NCD update. A short internal communication — one paragraph, the key point, the effective date — is enough. |
| 5 | Strengthen medical necessity documentation for covered cystic fibrosis cases. Because there's no prior auth requirement, CMS will rely on documentation review if a claim is audited. Make sure the chart supports the sweat test order in the context of a cystic fibrosis workup. If documentation is thin, work with your medical director to set a documentation standard before March 7, 2026. |
| 6 | If your practice has significant volume in this area or spans multiple specialties with peripheral vascular disease workups, loop in your compliance officer now. The retroactive exposure question — whether prior claims were billed correctly — is a compliance question, not just a billing operations question. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Sweat Test Under NCD 205
NCD 205 as modified does not list specific CPT codes, HCPCS codes, or ICD-10-CM diagnosis codes. This is an uncommon but not unprecedented structure for a CMS NCD — it establishes coverage intent and medical necessity criteria without enumerating specific procedure codes.
What This Means for Your Charge Capture
You are responsible for identifying the specific procedure codes your practice uses to bill sweat tests and confirming their alignment with this policy's coverage criteria. The absence of listed codes does not create ambiguity about coverage — the indication criteria are clear. It just means the code-matching work falls to your billing team.
Work with your billing consultant or coding team to identify the relevant codes in your charge master and cross-reference them against your payer contract terms and LCD (Local Coverage Determination) policies, which may provide more granular code-level guidance than this NCD.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.